Abstract
In this chapter, I propose the mechanism of cognitive enhancement based on studies of cognitive-enhancing drugs and behavioral training. I argue that there are mechanistic differences between cognitive-enhancing drugs and behavioral training due to their different enhancing effects. I also suggest possible mechanisms for cognitive-enhancing drugs and behavioral training and for the synergistic effects of their simultaneous application.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Berthier ML, Green C, Lara JP, Higueras C, Barbancho MA, Dávila G, Pulvermüller F (2009) Memantine and constraint-induced aphasia therapy in chronic poststroke aphasia. Ann Neurol 65:577–585
Cools R, Roberts AC, Robbins TW (2008) Serotoninergic regulation of emotional and behavioural control processes. Trends Cogn Sci 12:31–40
Harmer CJ (2008) Serotonin and emotional processing: does it help explain antidepressant drug action? Neuropharmacology 55:1023–1028
Husain M, Mehta MA (2011) Cognitive enhancement by drugs in health and disease. Trends Cogn Sci 15:28–36
Klingberg T, Fernell E, Olesen PJ, Johnson M, Gustafsson P, Dahlstrom K, Gillberg CG, Forssberg H, Westerberg H (2005) Computerized training of working memory in children with ADHD – a randomized, controlled trial. J Am Acad Child Adolesc Psychiatry 44:177–186
Knecht S, Breitenstein C, Bushuven S, Wailke S, Kamping S, Flöel A, Zwitserlood P, Ringelstein EB (2004) Levodopa: faster and better word learning in normal humans. Ann Neurol 56:20–26
Luciana M, Burgund ED, Berman M, Hanson KL (2001) Effects of tryptophan loading on verbal, spatial and affective working memory functions in healthy adults. J Psychopharmacol 15:219–230
Maguire EA, Valentine ER, Wilding JM, Kapur N (2003) Routes to remembering: the brains behind superior memory. Nat Neurosci 6:90–95
McNab F, Varrone A, Farde L, Jucaite A, Bystritsky P, Forssberg H, Klingberg T (2009) Changes in cortical dopamine D1 receptor binding associated with cognitive training. Science 323:800–802
Olesen PJ, Westerberg H, Klingberg T (2004) Increased prefrontal and parietal activity after training of working memory. Nat Neurosci 7:75–79
Robbins TW, Arnsten AFT (2009) The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci 32:267–287
Acknowledgement
In preparing the present version of this chapter I benefited from the written comments from Elisabeth Hildt, Sheila Madary, and Andreas G. Franke, and comments and suggestions from the participants in the conference on cognitive enhancement in Mainz, Germany, February 2011. I am grateful to the German Federal Ministry of Education and Research for supporting the trip to the conference and the preparation of this chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Chien, E.P. (2013). Cognitive-Enhancing Drugs, Behavioral Training and the Mechanism of Cognitive Enhancement. In: Hildt, E., Franke, A. (eds) Cognitive Enhancement. Trends in Augmentation of Human Performance, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6253-4_12
Download citation
DOI: https://doi.org/10.1007/978-94-007-6253-4_12
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6252-7
Online ISBN: 978-94-007-6253-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)